Detalhe da pesquisa
1.
Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer.
Cell
; 185(7): 1189-1207.e25, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325594
2.
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.
Immunity
; 38(4): 729-41, 2013 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23562161
3.
TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells.
Blood
; 126(26): 2781-9, 2015 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26508783
4.
Optimized protocol to generate genome-wide inactivated Cas9-expressing murine T cells.
STAR Protoc
; 4(1): 101922, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516053
5.
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity.
Nat Cancer
; 4(7): 968-983, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248395
6.
Acute Influenza Infection Promotes Lung Tumor Growth by Reprogramming the Tumor Microenvironment.
Cancer Immunol Res
; 11(4): 530-545, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883368
7.
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy.
Cancer Metastasis Rev
; 30(1): 61-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21249425
8.
Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma.
J Immunother Cancer
; 10(8)2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054452
9.
[Contributions of immunogenic cell death to the efficacy of anticancer chemotherapy]. / Contribution de la mort immunogène à l'efficacité de la chimiothérapie anticancéreuse.
Bull Mem Acad R Med Belg
; 166(3-4): 130-8; discussion 139-40, 2011.
Artigo
em Francês
| MEDLINE | ID: mdl-22375493
10.
In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4+ TH1 cell response.
Sci Immunol
; 6(66): eabe8219, 2021 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34860579
11.
Methods to edit T cells for cancer immunotherapy.
Methods Enzymol
; 631: 107-135, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948544
12.
A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsets.
J Exp Med
; 216(1): 133-151, 2019 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518599
13.
TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors.
Cancer Res
; 76(8): 2087-93, 2016 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27197251
14.
Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.
Mol Oncol
; 9(10): 1936-65, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26578451
15.
Trial watch: Cardiac glycosides and cancer therapy.
Oncoimmunology
; 2(2): e23082, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23525565
16.
Fluorescent biosensors for the detection of HMGB1 release.
Methods Mol Biol
; 1004: 43-56, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23733568
17.
Quantification of cell cycle-arresting proteins.
Methods Mol Biol
; 965: 121-42, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23296654
18.
Crosstalk between ER stress and immunogenic cell death.
Cytokine Growth Factor Rev
; 24(4): 311-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23787159
19.
Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death.
Autophagy
; 8(3): 413-5, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22361584
20.
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects.
Oncoimmunology
; 1(9): 1640-1642, 2012 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23264921